Table 1.
Patients | Age* | Sex | Refraction (SE) | Visual acuity before surgery* | PVR stage* | Total number of vitreoretinal surgeries* | Visual acuity final outcome** |
---|---|---|---|---|---|---|---|
1 | 65 | F | −1.00 | 0.4 | C2 | 2 | 0.4 |
2 | 58 | M | −1.50 | 0.2 | C2, CA1 | 2 | 0.3 |
3 | 67 | M | −1.00 | 0.3 | C3 | 2 | 0.2 |
4 | 62 | M | +1.75 | 0.1 | C6, CA2 | 5 | 0.1 |
5 | 62 | M | +2.00 | 0.1 | C8, CA3 | 6 | 0.05 |
6 | 45 | M | −7.50 | 0.02 | C7 | 2 | HM |
7 | 80 | M | +1.00 | HM | C6 | 4 | HM |
8 | 70 | F | 0 | 0.02 | C5 | 2 | HM |
9 | 72 | M | +1.00 | 0.2 | C4 | 1 | 0.2 |
10 | 51 | M | −1.00 | HM | C6 | 4 | 0.05 |
11 | 77 | M | 0 | HM | C7 | 2 | HM |
12 | 57 | M | −6.00 | HM | C11, CA4 | 2 | LP |
SE: spherical equivalent. HM: hand motion. LP: light perception. PVR: proliferative vitreoretinopathy. PVR stage: presence of preretinal or subretinal membranes posterior (C) or anterior (CA) to the equator of the eye, and number of clock hours involved (from 1 to 12). *at the time of retinectomy in PVR surgery. **six months after surgery.